9 Peptides from Her-2/neu, CEA, & CTA
Sponsors
Craig L Slingluff, Jr
Conditions
Breast CancerBreast Neoplasms
Phase 1
Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer
CompletedNCT00892567
Start: 2009-05-31End: 2012-02-29Updated: 2016-12-16
Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer
TerminatedNCT01532960
Start: 2012-07-31End: 2015-09-30Updated: 2020-05-08